These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2481157)

  • 1. Beta-blockade after myocardial infarction: practical implications of major clinical trials.
    Rehnqvist N; Olsson G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S10-4. PubMed ID: 2481157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial infarction. Effects of beta-blockade.
    Hjalmarson A; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI101-7. PubMed ID: 1683604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction.
    Pedersen TR
    N Engl J Med; 1985 Oct; 313(17):1055-8. PubMed ID: 2864634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.
    Eur Heart J; 1988 Jan; 9(1):8-16. PubMed ID: 2894312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic blockers in patients with acute myocardial infarction.
    Furberg CD; Byington RP
    Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor blockade: past, present, and future.
    Dollery CT
    J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S1-4. PubMed ID: 2464091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do results from major clinical trials indicate a change in management in the acute phase of myocardial infarction?
    Hjalmarson A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S2-8; discussion S9. PubMed ID: 2481164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-myocardial infarction beta-blocker therapy: the bradycardia conundrum. Rationale and design for the Pacemaker & beta-blocker therapy post-MI (PACE-MI) trial.
    Goldberger JJ; Bonow RO; Cuffe M; Dyer A; Greenland P; Rosenberg Y; O'Rourke R; Shah PK; Smith S
    Am Heart J; 2008 Mar; 155(3):455-64. PubMed ID: 18294477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of treatments with beta-blockaders after myocardial infarction].
    Haïat R; Roussin I; Leroy G
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1697-702. PubMed ID: 1363902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers in chronic treatment after acute myocardial infarction.
    Fogari R; Zoppi A
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S68-71. PubMed ID: 2483236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.